Wu, K., Li, S., Hong, G., Dong, H., Tang, T., Liu, H., . . . Wu, H. (2024). Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy. Clinical & Translational Medicine, 14(11), 1. https://doi.org/10.1002/ctm2.70089
Chicago Style (17th ed.) CitationWu, Kaixin, et al. "Targeting METTL3 as a Checkpoint to Enhance T Cells for Tumour Immunotherapy." Clinical & Translational Medicine 14, no. 11 (2024): 1. https://doi.org/10.1002/ctm2.70089.
MLA (9th ed.) CitationWu, Kaixin, et al. "Targeting METTL3 as a Checkpoint to Enhance T Cells for Tumour Immunotherapy." Clinical & Translational Medicine, vol. 14, no. 11, 2024, p. 1, https://doi.org/10.1002/ctm2.70089.
Warning: These citations may not always be 100% accurate.